Ciba and Lovelace launch disease management program for epilepsy.SUMMIT, N.J. & ALBUQUERQUE, N.M. --(HealthWire)--Sept. 12, 1996--Ciba Pharmaceuticals and Lovelace Healthcare Innovations Inc. announced today that they have reached an agreement to collaborate on a disease management program for the treatment of epilepsy. Lovelace will develop an Epilepsy Episodes of Care(TM) program, a comprehensive healthcare treatment program for the diagnosis and treatment of epilepsy. Ciba will assist by providing outcomes analysis and validation of the program, and will provide educational materials for use in conjunction with Lovelace's disease management guidelines. Ciba and Lovelace also plan jointly to publish articles about their work. The agreement brings the two different organizations together. Ciba will provide its expertise in epilepsy drug therapies, medical marketing and education, pharmacoeconomics and outcomes research, as well as its long standing relationships with the neurology community and patient advocacy Patient advocacy refers to speaking on behalf of a patient in order to protect their rights and help them obtain needed information and services. The role of patient advocate is frequently assumed by nurses, social workers, and other healthcare providers. groups. Lovelace will contribute its expertise in providing comprehensive health-care solutions for the managed care community, including training, education, as well as development, implementation and testing of disease management programs, clinical trials and information systems. "Ciba's agreement with Lovelace is a significant step for Ciba and for the managed care community: It marks Ciba's entry into disease management, and it is a program designed to be a true partnership between a pharmaceutical company and an integrated healthcare system," said Diana Brixner, R. Ph., Ph.D., director of pharmaceutical outcomes research for Ciba Pharmaceuticals. "By combining our respective strengths, we hope to optimize value for our customers and learn of opportunities to improve upon the care of epilepsy." "We're very excited to be working with Ciba. This program is a wonderful opportunity for both organizations to learn from each other. We look forward to its success and future projects," said John Byrnes, M.D., vice president of quality for Lovelace Healthcare Innovations Inc. Epilepsy is a chronic disorder Chronic Disorder is a rock/punk band formed in the early 1980s in Connecticut, now active in Seattle. Discography
tr.v. af·flict·ed, af·flict·ing, af·flicts To inflict grievous physical or mental suffering on. [Middle English afflighten, from afflight, over two million people in the U.S., or approximately one percent of the population. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the Epilepsy Foundation of America The Epilepsy Foundation, also Epilepsy Foundation of America (EFA), is a non-profit national foundation, headquartered in Landover, Maryland, dedicated to the welfare of people with epilepsy and seizure disorders. (EFA EFA essential fatty acid. ), while almost 85 percent of all cases can be controlled through proper use of medications , this target can only be achieved for a patient through a well designed and implemented treatment plan. Without such a plan, treatment may be inconsistent and desired outcomes may be sporadic. Ciba Pharmaceuticals, headquartered in Summit, is a division of Ciba-Geigy Corporation of Tarrytown, N.Y., a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Ciba-Geigy Limited of Basel, Switzerland. Ciba is a leading developer and manufacturer of health-care and agricultural products and specialty chemicals for industry. Ciba Pharmaceuticals is dedicated to discovering, developing, manufacturing and marketing innovative pharmaceuticals that meet unmet medical needs and improve patients' quality of life. CibaGeneva is a marketing alliance of Ciba Pharmaceuticals and its affiliate, Geneva Geneva, canton and city, Switzerland Geneva (jənē`və), Fr. Genève, canton (1990 pop. 373,019), 109 sq mi (282 sq km), SW Switzerland, surrounding the southwest tip of the Lake of Geneva. Pharmaceuticals Inc. of Broomfield, Colo. CibaGeneva is dedicated to anticipating and meeting the needs of existing and emerging customers in the U.S. healthcare U.S. Healthcare is a now-defunct healthcare company. The logo had an apple. The merger with Aetna In 1996, the company merged with Aetna, calling it Aetna U.S. Healthcare. The U.S. Healthcare apple logo was next to the Aetna name, and U.S. Healthcare under it. U.S. market by offering high-quality branded and generic pharmaceuticals and innovative medical solutions. Lovelace Healthcare Innovations (LHI LHI Local Heritage Initiative LHI Leading Health Indicator LHI Leasehold Improvement LHI Lars Hoej Informatik A/S (Danish translation technology company) LHI Lipschitz-Hankel Integral ), based in Albuquerque, is a subsidiary of Lovelace Clinic Foundation and a member of the Lovelace family of organizations. LHI coordinates the development and implementation of the Episodes of Care disease management program within Lovelace Healthcare Systems (LHS (filename extension) lhs - The filename extension for literate Haskell source files. ), the largest integrated healthcare system in New Mexico. LHI and LHS are recognized nationally for continued innovation in the delivery of quality focused health care, including disease management. CONTACT: Ciba Pharmaceuticals, Summit Mary-Frances Faraji, 908/277-5290 or Lovelace Healthcare Innovations, Albuquerque Anne Monson, 505/262-3640 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion